Hospital notice: these departments stop using key monitoring varieties!

On October 28, the health and Health Commission of Hubei Province released the catalogue of the first batch of drugs for key monitoring and rational use of drugs in Hubei Province Since July 1, the national health and Health Commission issued the first batch of key monitoring directories, each province has successively released its own key monitoring directories Some provinces directly follow the national version, while others make some adjustments based on the national version According to the catalogue of the first batch of key monitoring drugs for rational use in Hubei Province, there are 25 key monitoring varieties In addition to the 20 varieties listed in the national catalogue, five varieties have been added in Hubei Province, three of which are traditional Chinese medicine injections Hubei Provincial Health and Health Commission requires that the health and health commissions of all cities (prefectures) shall be responsible for collecting the catalogue of drugs for rational use under the key monitoring of medical institutions above the second level within their jurisdiction, and submit it to the provincial health and Health Commission before November 30 The medical institutions under the Ministry and province shall be directly reported to the provincial health and Health Commission The first batch of key monitoring catalogue of Hubei Province is as follows: According to the requirements of the previous notice of the national health and Health Commission, for the drugs that have not been included in the catalog management, the routine clinical use monitoring work shall be done well, and the problems such as abnormal increase in the use amount, no indication and excessive dose use shall be found, and the early warning shall be strengthened and the causes shall be found Those who violate laws and regulations shall be dealt with seriously At the same time, the National Health Commission has made it clear that it will dynamically adjust the catalogue with the State Administration of traditional Chinese medicine About this content, Hubei Health Committee's notice also involves In addition to the key monitoring drugs, Hubei health and Health Commission requires that the management of drugs not in the key monitoring directory should also be strengthened Medical institutions shall strictly implement the clinical use monitoring and abnormal early warning mechanism for non key monitoring of rational use of drugs, timely evaluate the abnormal use, and make clear that the unreasonable use of drugs shall be timely included in the key monitoring directory of the institution In addition, Hubei health and Health Commission has made it clear that it will make dynamic adjustment to the provincial directory on a regular basis, and all medical institutions should adjust their own directory in time according to the dynamic adjustment of the provincial directory Like the medical insurance catalog, dynamic adjustment must be in and out Therefore, in the process of dynamic adjustment, some varieties may try to remove the "hat" of key monitoring, or some varieties may be moved into the scope of key monitoring due to the abnormal increase of usage, no indication, over dose use and other problems Recently, a personage in the industry has provided a document for cypress blue to monitor the use of drugs in various departments, which is from a top three hospital in Hubei Province The hospital's list of key monitoring drugs includes 31 varieties, including 8 traditional Chinese medicine injections It can be found by comparison that this catalogue has been adjusted on the basis of provincial catalogue Whether these 31 key monitored varieties are the key monitored drugs catalogue that the hospital will finally report remains to be studied Looking at the above table, we can see that many key monitoring varieties are widely used in many departments The red column in the table indicates that these departments should gradually stop using the key monitoring varieties, and the green column is the departments that can receive the key monitoring varieties within the scope of application In addition, the hospital clearly stipulated that all key monitored varieties should be collected in a limited amount, and each department could not suddenly increase the dosage within the allowed range of varieties, resulting in the overall shortage In the case of key monitoring and limited use, the departments in the applicable scope should be reasonably used, and the departments that should not be used should not be used The use of key monitoring drugs is expected to gradually become reasonable This is also the original intention of the state to establish the directory of key monitoring rational drug use On August 20, the State Medical Security Bureau and the Ministry of human resources and social security explicitly mentioned in the notice on printing and distributing: